Flecainide With Ranolazine Combination Inhibits Nav 1.5 Activity of Triple-Negative Breast Cancer Cells (MDA-MB-231) - MAMMADOVA, G.; DEMİREL, M.; ALTUN, SEYHAN (Wiley, 2025)